UPDATE: Edwards Q4 Profit Surges 44%

Edwards Lifesciences

reported a 44% rise in its fourth-quarter profit. Edwards' quarterly profit surged to $91.1 million, or $0.77 per share, from $63.1 million, or $0.53 per share, in the year-ago period. Excluding special items, it earned $0.90 per share. Its sales climbed 19% to $510.5 million. Edwards in October expected earnings of $0.76 to $0.80 per share on revenue of $490 million to $520 million. Its gross margin rose to 75.4% from 72.2%. Edwards shares gained 0.45% to $93.48 in after-hours trading.